Automated Cell Biology Systems Market Snapshot (2022 to 2032)

By the end of 2022, the global automated cell biology systems market is anticipated to be worth US$ 14.1 Billion, and it will grow at a CAGR of 9.0% to reach an expected valuation of around US$ 33.5 Billion by the year 2032. Infinite cell line cultures dominate the worldwide market in 2021, with a share of around 76.2%, according to a recent analysis by Future Market Insights.

Market Outlook:

Data Points Market Insights
Market Value 2022 US$ 14.1 Billion
Market Value 2032 US$ 33.5 Billion
CAGR 2022 to 2032 9.0%
Market Share of Top 5 Countries 62.3%
Key Market Players Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza, Sartorius AG, Hitachi. Ltd, Nanoentek, ChemoMetec, Danaher Corporation, Agilent Technologies, Perkin Elmer (Nexcelom Bioscience LLC.), F. Hoffmann-La Roche AG, SHIMADZU CORPORATION, Bio-Rad Laboratories, Miltenyi Biotec, Sinfonia Technology, SHIBUYA CORPORATION, Advanced Instruments, Cell Culture Company, LLC, BD, and Hamilton Company

Compared to the widespread methods utilized in the second half of the twentieth century, modern cell cultivation techniques are not significantly different. Despite the fact that these techniques made it possible to comprehend a variety of biological processes and that they served as determining factors for applications like drug testing and tissue regeneration, they had a number of inherent drawbacks. In actuality, conventional cell culture systems necessitate numerous and intricate manual handling techniques, which restricts the consistency of the cultivation in terms of cell yield and activity.

Additionally, long-term cell maintenance is costly, time-consuming, and demands a lot of reagents, test samples, and work. By reducing the number of operator interventions, the shift to user-friendly automated devices would favor standardizing the cultivation process, cutting production costs, and shortening the time required for cell culture preparation, thus promoting market growth for automated cell biology systems.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Automated Cell Biology Systems Market from 2015 to 2021 Vs Market Outlook for 2022 to 2032

The market value for automated cell biology systems was approximately 65.8% of the overall ~US$ 19.9 Billion global bioprocess technology market in 2021.

The sale of automated cell biology systems expanded at a CAGR of 6.6% from 2015 to 2021.

Technologies like microfluidics and lab-on-a-chip represent a strategic approach to support the shift to user-friendly automated equipment. By using microculture systems in place of conventional Petri plates and flasks for cellular tests, researchers have been able to minimize the number of reagents used while still achieving high-throughput cell generation and culture in a controlled setting.

The development of tissue engineering aims to increase the possibility of replacing tissue development for regenerating or restoring organ and tissue function. Tissue engineering technology has advanced significantly in recent years, and it is now widely used in domains other than medicine, such as organs-on-a-chip, bioelectronic devices, cultured meats, and so on.

Cell culture is the primary method used for tissue engineering manufacturing. Therefore, it is crucial for tissue engineering research to maintain high standards for cell culture settings.

Modern uses of analytical system automation include clinical, pharmacological, and biomedical environments. The automatic system has played a significant role in both qualitative and quantitative analysis. Optically driven, electrochemical, and mass spectroscopic approaches have all been used as analytical techniques. Robotic automation lowers the cost of analysis while providing high precision and high system throughput.

Numerous lab-on-chip advancements have been made for cell culture and certain other biomedical applications. A cell culture device indicates the viability of the cells, nutrient consumption, nutrient output in the fermentation process, and pharmacological effect.

Because of the aforementioned factors, it is anticipated that from 2022 to 2032, the global automated cell biology systems market will expand at a CAGR of 9.0%.

Automated Cell Biology Systems Market

What are the Major Opportunities in the Global Automated Cell Biology Systems Market?

As automated cell culture, on-chip is widely acknowledged as a benchmark parameter in existing microfluidic systems for cell biology, and a plethora of studies have been documented in the literature. At the research laboratory level, the minimization and downsizing of additional peripheral equipment are considered a fundamental necessity for the utilization of automated devices in cell culture, coupled with the need for systems that are ready-to-use in a plug-and-play mode.

Currently, the use of micro-devices for fluidic control is limited to the use of relatively complicated, specialized, and bulky external equipment and macro-to-micro interface systems, necessitating the ongoing assistance of human operators to manage fluid flow in an unstandardized and manual manner.

The systematic application of a suitably integrated control system for accurate fluid handling in a remote control framework will significantly improve the usability and readout dependability of micro-bioreactors. This is crucial in automating cell culture techniques, reducing human involvement, and significantly lowering the number of connection tubes, intake and output ports, and bulky external equipment.

The adoption of such control systems is gaining traction, owing to the above-mentioned factors, and this is set to pose lucrative opportunities for growth within the global automated cell biology systems market during the forecasted years.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Limiting Demand for Automated Cell Biology Systems?

Cell-based therapies have the ability to provide a successful treatment for medical disorders that are presently incurable. Their widespread commercialization has been put at risk by constraints such as scaling up and automating labor-intensive research discoveries, high production costs, and batch variance in large-scale automated manufacturing.

Additionally, even though many cell culture labs employ automated tools to do away with manual duties like handling plates, highly-trained lab staff are still required to spend hours every day maintaining these devices. As a result, the majority of benchtop automation has limitations in terms of scaling in cell culture facilities.

Furthermore, the utilization of mammalian cell culture is quickly expanding. Even though the fundamental processes for sustaining cells are quite repeatable, the majority of cell culture operations are still done by hand.

Personnel is required to perform repetitive tasks for hours on end each day, and frequently they must come in after regular working hours to cater to the cells or modify their biology to accommodate the workload. Both the workflow's throughput and its ability to be tracked are limited by this dependence on manual steps.

With the above-mentioned factors, the market for automated cell biology systems experiences a restraint in growth.

Country-wise Insights

What Makes the USA a Large Market for Automated Cell Biology Systems?

With a market share of 89.8% in all of North America in 2021, the USA presently dominates the region and is expected to sustain this growth throughout the forecast period.

The increasing expenditure on Research and Development in the area can be attributed to the market's expansion. Additionally, the expansion of pharmaceutical firms and manufacturers in the area together with rising public awareness of stem cell therapy is anticipated to significantly contribute to the market's expansion. Additionally, it is predicted that the rising number of bone marrow and cord blood transplants across the region will favorably influence market growth.

What Makes China a Highly Lucrative Market for Automated Cell Biology Systems?

China represents roughly 64.9% of the East Asia market in 2021, with growth at a lucrative CAGR of 13.7% throughout the forecast period. China has a significant demand for automation, according to the International Federation of Robotics (IFR). According to sales volume, China was one of the top five markets for industrial robots in 2015.

The China Robot Industry Alliance estimates that Chinese robot suppliers sold about 20,400 units in 2015, increasing their share of the global market from 25% to 29% from 2013 until 2015. With the growing wave in automation, as well as its adoption, China is posed to be a highly lucrative market for automated cell biology systems over the forecast period.

What is the Outlook of Germany in the Automated Cell Biology Systems Market?

During the forecast years, Germany is projected to grow at a CAGR of nearly 7.2% in the global automated cell biology systems market. The European Medicinal Agency (EMA) granted the CliniMACS Prodigy platform approval for the commercial manufacturing process in 2018 for the customization of protocols, which is accomplished through modularity and flexible programming, allowing its use for a number of different cell types, including the development of CAR-T cells, macrophages, virus-specific T-cells, and dendritic cells. With the manufacturing of such capable platforms, Germany is set to aid with the growth of the overall market during the projected period.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which Product is Widely Adopted within the Global Automated Cell Biology Systems Market?

Automated cell counters (single function) are the leading segment as a product, hold approximately 34.6% market share in 2021, and are expected to present high growth at a CAGR of 8.1% throughout the forecast period. The benefit of using an automated cell counter is that it largely eliminates human bias from the cell counting process. They can count more cells and are frequently faster than manually counting, which improves statistical accuracy. Automated cell counters are also employed in research and clinical labs. They can be used on urine and blood samples to count the different cell types present or to evaluate the viability of a cultivated cell line for investigation.

Which Cell Cultures are Largely in Focus within the Automated Cell Biology Systems Market?

Infinite cell line cultures hold a global market share of around 76.2%, in 2021. Infinite cell line cultures are more robust and convenient to work with than primary cells since they can reproduce indefinitely. Infinite cell line cultures are also convenient for researchers because they are less expensive, easier to use, and able to survive more stages than primary cells. Because cell lines have a limitless supply of material and are simple to alter and grow, they are preferred for multiple screenings.

Which Application of Automated Cell Biology Systems is Widely Taken over Globally?

Drug development holds a share of around 35.4% in 2021, and this segment is expected to display gradual growth over the forecast period. New scientific developments in basic research, drug development, drug discovery, and customized medicine applications are being driven by 3D cell cultures. To understand the full potential of the technology, researchers can operate more efficiently with complex reagents and precious cells with the aid of high throughput, automated liquid handling solutions.

How are Biopharmaceutical Companies Major End Users for Automated Cell Biology Systems?

Biopharmaceutical companies hold the highest market share value of 27.4% during the year 2021. Growing drug development activities propelled by the rising demand for personalized medicine will propel this segment in terms of growth during the projected years. With the standardization of laboratory protocols, as well as the utilization of automated systems for process control technologies during the production process, this segment gains a higher share among the rest of the end users within the global market.

Competitive Landscape

Key players in the market present novel solutions for the lab automation processes for cell biology systems. Moreover, with increasing approvals from the regulatory authorities for software-based total lab automation systems, the key players are presented with an opportunistic outlook for growth during the forecast period.

  • Thermo Fisher launched a closed and automated cell isolation and bead removal solution in October 2022 to aid in the advancement of cell therapy manufacturing.
  • By purchasing Lonza's MAST® Platform, a prominent automated bioreactor sampling system, in April 2022, Merck will advance bioprocessing capabilities.

Similarly, recent developments related to companies manufacturing automated cell biology systems have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as per Automated Cell Biology Systems Industry Analysis

Attribute Details
Forecast Period 2022 to 2032
Historical Data Available for 2015 to 2021
Market Analysis US$ Billion for Value
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa
Key Market Segments Covered Product, Cell Culture, Application, End User, and Region
Key Companies Profiled
  • Thermo Fisher Scientific
  • Corning Incorporated
  • Merck KGaA
  • Lonza
  • Sartorius AG
  • Hitachi. Ltd
  • Nanoentek
  • ChemoMetec
  • Danaher corporation
  • Agilent Technologies
  • Perkin Elmer (Nexcelom Bioscience LLC.)
  • F. Hoffmann-La Roche AG
  • SHIMADZU CORPORATION
  • Bio-Rad Laboratories
  • Miltenyi Biotec
  • Sinfonia Technology
  • SHIBUYA CORPORATION
  • Advanced Instruments
  • Cell Culture Company, LLC
  • BD
  • Hamilton Company
Pricing Available upon Request

Key Market Segments Covered in Automated Cell Biology Systems Industry Research

By Product:

  • Cell Culture Process Automatization Instrument or Robot (Multiple Function)
  • Automated Bioreactor (Single or Multiple Function)
  • Automated Cell Culture Media Exchange System (Single Function)
  • Automated Culture Media Analyzer (Single Function)
  • Automated Cell Wash-and-Concentrate System (Single Function)
  • Automated Cell Counter (Single Function)
  • Automated Fill And Finish System (Single Function)
  • Automated Cell Storage Equipment (Single Function)
  • Management Software

By Cell Culture:

  • Finite Cell Line Cultures
  • Infinite Cell Line Cultures

By Application:

  • Cell Therapy
  • Drug Development
  • Stem Cell Research
  • Regenerative Medicine

By End User:

  • Mega Pharmaceutical companies
  • Biopharmaceutical companies
  • CDMOs/CMOs
  • Research organizations
  • Academic institutes

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

How much is the Automated Cell Biology Systems Market estimated worth in 2022?

The global automated cell biology systems market stands at US$ 14.1 Billion in 2022 and is set to expand 2.4X over the next ten years.

What is the sales forecast for automated cell biology systems through 2032?

The automated cell biology systems market is expected to reach US$ 33.5 Billion by end of 2032 at a CAGR of 9.0%.

What are the trends driving the demand outlook of the global automated cell biology systems market?

The growing geriatric population, the rising burden of chronic and infectious diseases, and rising Research and Development on novel biopharmaceuticals are some of the key trends in this market.

Which region has the highest market share in the global automated cell biology systems market?

By region, North America holds the highest market share of around 37.4% by value, in 2021, in the global automated cell biology systems market.

How likely is the automated cell biology systems market to grow in Europe?

Europe is projected to grow with a CAGR of 7.5% during the forecast period.

Which are the top five countries driving demand for automated cell biology systems market?

The USA, Germany, India, China, and the United Kingdom are the top five countries, which are expected to drive demand in the automated cell biology systems market.

Who are the key manufacturers in the automated cell biology systems market?

Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza, Sartorius AG, Hitachi. Ltd, Nanoentek, ChemoMetec, Danaher Corporation, Agilent Technologies, Perkin Elmer (Nexcelom Bioscience LLC.), F. Hoffmann-La Roche AG, SHIMADZU CORPORATION, Bio-Rad Laboratories, Miltenyi Biotec, Sinfonia Technology, SHIBUYA CORPORATION, Advanced Instruments, Cell Culture Company, LLC, BD, and Hamilton Company, are some of the key players in the automated cell biology systems industry.

What was the last 6 years’ CAGR value growth for the automated cell biology systems market?

From 2015 to 2021, the market for automated cell biology systems expanded at the rate of 6.6% CAGR.

What are the key market statistics for South Asia in the automated cell biology systems market?

The automated cell biology systems market in South Asia is expected to grow at 12.3% CAGR during the forecast period.

What is the outlook of East Asia in the automated cell biology systems market?

East Asia is set to present lucrative growth at a CAGR of 13.1% during the forecasted years.

What are the key market statistics for South Asia in the automated cell biology systems market?

The automated cell biology systems market in South Asia is expected to grow at 12.3% CAGR during the forecast period.

What is the outlook of East Asia in the automated cell biology systems market?

East Asia is set to present lucrative growth at a CAGR of 13.1% during the forecasted years.

Table of Content
1. Executive Summary | Automated Cell Biology Systems Market
    1.1. Global Market Outlook
    1.2. Demand Side Trends
    1.3. Supply Side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
    2.3. Inclusions and Exclusions
3. Key Market Trends
    3.1. Key Trends Impacting the Market
    3.2. Innovation / Development Trends
4. Key Success Factors
    4.1. Product Adoption Analysis
    4.2. Regulatory Landscape
    4.3. Reimbursement Scenario
    4.4. PESTEL Analysis
    4.5. Porter’s Analysis
    4.6. Value Chain Analysis
5. Market Background
    5.1. Macro-Economic Factors
        5.1.1. Global GDP Growth Outlook
        5.1.2. Global Healthcare Outlook
        5.1.3. Global Market Overview
    5.2. Forecast Factors - Relevance & Impact
        5.2.1. Increasing Prevalence of Chronic and Infectious Diseases
        5.2.2. Growing Elderly Population
        5.2.3. Growing Efforts on Stem Cell Research
        5.2.4. Increasing Demand for Gene Therapies
        5.2.5. Rising Biopharmaceutical Production
        5.2.6. Growing Investments in R&D
        5.2.7. Rising Adoption of Automated Systems for Bulk Manufacturing
        5.2.8. Increasing Focus on New Drug Discovery and Development
    5.3. Market Dynamics
        5.3.1. Drivers
        5.3.2. Restraints
        5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
    6.1. COVID-19 and Impact Analysis
        6.1.1. By Product
        6.1.2. By Application
        6.1.3. By Cell Culture
        6.1.4. By End User
        6.1.5. By Country
    6.2. 2021 Market Scenario
7. Global Market Volume (Units) Analysis 2015 to 2021 and Forecast, 2022 to 2032
    7.1. Historical Market Volume (Units) Analysis, 2015 to 2021
    7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032
        7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
    8.1. Regional Pricing Analysis By Product
    8.2. Pricing Break-up
        8.2.1. Manufacturer-Level Pricing
        8.2.2. Distributor Level Pricing
    8.3. Global Average Pricing Analysis Benchmark
    8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Million) Analysis 2015 to 2021 and Forecast, 2022 to 2032
    9.1. Historical Market Value (US$ Million) Analysis, 2015 to 2021
    9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
        9.2.1. Y-o-Y Growth Trend Analysis
        9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis, By Product
    10.1. Introduction / Key Findings
    10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2015 to 2021
    10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2022 to 2032
        10.3.1. Cell Culture Process Automatization Instrument or Robot (Multiple Function)
        10.3.2. Automated Bioreactor (Single or Multiple Function)
        10.3.3. Automated Cell Culture Media Exchange System (Single Function)
        10.3.4. Automated Culture Media Analyzer (Single Function)
        10.3.5. Automated Cell Wash-and-Concentrate System (Single Function)
        10.3.6. Automated Cell Counter (Single Function)
        10.3.7. Automated Fill and Finish System (Single Function)
        10.3.8. Automated Cell Storage Equipment (Single Function)
        10.3.9. Management Software
    10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis, By Cell Culture 
    11.1. Introduction / Key Findings
    11.2. Historical Market Size (US$ Million) Analysis By Cell Culture, 2015 to 2021
    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Cell Culture, 2022 to 2032
        11.3.1. Finite Cell Line Cultures
        11.3.2. Infinite Cell Line Cultures
    11.4. Market Attractiveness Analysis By Cell Culture
12. Global Market Analysis, By Application
    12.1. Introduction / Key Findings
    12.2. Historical Market Size (US$ Million) Analysis, By Application, 2015 to 2021
    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2032
        12.3.1. Cell Therapy
        12.3.2. Drug Development
        12.3.3. Stem Cell Research
        12.3.4. Regenerative Medicine
    12.4. Market Attractiveness Analysis By Application
13. Global Market Analysis, By End User 
    13.1. Introduction / Key Findings
    13.2. Historical Market Size (US$ Million) Analysis, By End User, 2015 to 2021
    13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032
        13.3.1. Mega Pharmaceutical companies
        13.3.2. Biopharmaceutical companies
        13.3.3. CDMOs/CMOs
        13.3.4. Research organizations
        13.3.5. Academic institutes
    13.4. Market Attractiveness Analysis By End User
14. Global Market Analysis, By Region
    14.1. Introduction
    14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2015 to 2021
    14.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032
        14.3.1. North America
        14.3.2. Latin America
        14.3.3. Europe
        14.3.4. East Asia
        14.3.5. South Asia
        14.3.6. Oceania
        14.3.7. Middle East and Africa (MEA)
    14.4. Market Attractiveness Analysis By Region
15. North America Market Analysis
    15.1. Introduction
    15.2. Historical Market Size (US$ Million) Trend and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
    15.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032
        15.3.1. By Country
            15.3.1.1. USA
            15.3.1.2. Canada
        15.3.2. By Product
        15.3.3. By Application
        15.3.4. By Cell Culture
        15.3.5. By End User
    15.4. Market Attractiveness Analysis
        15.4.1. By Country
        15.4.2. By Product
        15.4.3. By Cell Culture
        15.4.4. By Application
        15.4.5. By End User
    15.5. Market Trends
    15.6. Drivers and Restraints - Impact Analysis
    15.7. Country-Level Analysis & Forecast
        15.7.1. USA Market Analysis
            15.7.1.1. Introduction
            15.7.1.2. Market Analysis and Forecast by Market Taxonomy
                15.7.1.2.1. By Product
                15.7.1.2.2. By Cell Culture
                15.7.1.2.3. By Application
                15.7.1.2.4. By End User
        15.7.2. Canada Market Analysis
            15.7.2.1. Introduction
            15.7.2.2. Market Analysis and Forecast by Market Taxonomy
                15.7.2.2.1. By Product
                15.7.2.2.2. By Cell Culture
                15.7.2.2.3. By Application
                15.7.2.2.4. By End User
16. Latin America Market Analysis
    16.1. Introduction
    16.2. Historical Market Size (US$ Million) Trend and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
    16.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032
        16.3.1. By Country
            16.3.1.1. Mexico
            16.3.1.2. Brazil
            16.3.1.3. Argentina
            16.3.1.4. Rest of Latin America
        16.3.2. By Product
        16.3.3. By Cell Culture
        16.3.4. By Application
        16.3.5. By End User
    16.4. Market Attractiveness Analysis
        16.4.1. By Country
        16.4.2. By Product
        16.4.3. By Cell Culture
        16.4.4. By Application
        16.4.5. By End User
    16.5. Market Trends
    16.6. Drivers and Restraints - Impact Analysis
    16.7. Country-Level Analysis & Forecast
        16.7.1. Mexico Market Analysis
            16.7.1.1. Introduction
            16.7.1.2. Market Analysis and Forecast by Market Taxonomy
                16.7.1.2.1. By Product
                16.7.1.2.2. By Cell Culture
                16.7.1.2.3. By Application
                16.7.1.2.4. By End User
        16.7.2. Brazil Market Analysis
            16.7.2.1. Introduction
            16.7.2.2. Market Analysis and Forecast by Market Taxonomy
                16.7.2.2.1. By Product
                16.7.2.2.2. By Cell Culture
                16.7.2.2.3. By Application
                16.7.2.2.4. By End User
        16.7.3. Argentina Market Analysis
            16.7.3.1. Introduction
            16.7.3.2. Market Analysis and Forecast by Market Taxonomy
                16.7.3.2.1. By Product
                16.7.3.2.2. By Cell Culture
                16.7.3.2.3. By Application
                16.7.3.2.4. By End User
17. Europe Market Analysis
    17.1. Introduction
    17.2. Historical Market Size (US$ Million) Trend and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
    17.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032
        17.3.1. By Country
            17.3.1.1. Germany
            17.3.1.2. Italy
            17.3.1.3. France
            17.3.1.4. United Kingdom
            17.3.1.5. Spain
            17.3.1.6. BENELUX
            17.3.1.7. Russia
            17.3.1.8. Rest of Europe
        17.3.2. By Product
        17.3.3. By Cell Culture
        17.3.4. By Application
        17.3.5. By End User
    17.4. Market Attractiveness Analysis
        17.4.1. By Country
        17.4.2. By Product
        17.4.3. By Cell Culture
        17.4.4. By Application
        17.4.5. By End User
    17.5. Market Trends
    17.6. Drivers and Restraints - Impact Analysis
    17.7. Country-Level Analysis & Forecast
        17.7.1. Germany Market Analysis
            17.7.1.1. Introduction
            17.7.1.2. Market Analysis and Forecast by Market Taxonomy
                17.7.1.2.1. By Product
                17.7.1.2.2. By Cell Culture
                17.7.1.2.3. By Application
                17.7.1.2.4. By End User
        17.7.2. Italy Market Analysis
            17.7.2.1. Introduction
            17.7.2.2. Market Analysis and Forecast by Market Taxonomy
                17.7.2.2.1. By Product
                17.7.2.2.2. By Cell Culture
                17.7.2.2.3. By Application
                17.7.2.2.4. By End User
        17.7.3. France Market Analysis
            17.7.3.1. Introduction
            17.7.3.2. Market Analysis and Forecast by Market Taxonomy
                17.7.3.2.1. By Product
                17.7.3.2.2. By Cell Culture
                17.7.3.2.3. By Application
                17.7.3.2.4. By End User
        17.7.4. United Kingdom Market Analysis
            17.7.4.1. Introduction
            17.7.4.2. Market Analysis and Forecast by Market Taxonomy
                17.7.4.2.1. By Product
                17.7.4.2.2. By Cell Culture
                17.7.4.2.3. By Application
                17.7.4.2.4. By End User
        17.7.5. Spain Market Analysis
            17.7.5.1. Introduction
            17.7.5.2. Market Analysis and Forecast by Market Taxonomy
                17.7.5.2.1. By Product
                17.7.5.2.2. By Cell Culture
                17.7.5.2.3. By Application
                17.7.5.2.4. By End User
        17.7.6. BENELUX Market Analysis
            17.7.6.1. Introduction
            17.7.6.2. Market Analysis and Forecast by Market Taxonomy
                17.7.6.2.1. By Product
                17.7.6.2.2. By Cell Culture
                17.7.6.2.3. By Application
                17.7.6.2.4. By End User
        17.7.7. Russia Market Analysis
            17.7.7.1. Introduction
            17.7.7.2. Market Analysis and Forecast by Market Taxonomy
                17.7.7.2.1. By Product
                17.7.7.2.2. By Cell Culture
                17.7.7.2.3. By Application
                17.7.7.2.4. By End User
18. East Asia Market Analysis
    18.1. Introduction
    18.2. Historical Market Size (US$ Million) Trend and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
    18.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032
        18.3.1. By Country
            18.3.1.1. China
            18.3.1.2. Japan
            18.3.1.3. South Korea
        18.3.2. By Product
        18.3.3. By Cell Culture
        18.3.4. By Application
        18.3.5. By End User
    18.4. Market Attractiveness Analysis
        18.4.1. By Country
        18.4.2. By Cell Culture
        18.4.3. By Product
        18.4.4. By Application
        18.4.5. By End User
    18.5. Market Trends
    18.6. Drivers and Restraints - Impact Analysis
    18.7. Country-Level Analysis & Forecast
        18.7.1. China Market Analysis
            18.7.1.1. Introduction
            18.7.1.2. Market Analysis and Forecast by Market Taxonomy
                18.7.1.2.1. By Product
                18.7.1.2.2. By Cell Culture
                18.7.1.2.3. By Application
                18.7.1.2.4. By End User
        18.7.2. Japan Market Analysis
            18.7.2.1. Introduction
            18.7.2.2. Market Analysis and Forecast by Market Taxonomy
                18.7.2.2.1. By Product
                18.7.2.2.2. By Cell Culture
                18.7.2.2.3. By Application
                18.7.2.2.4. By End User
        18.7.3. South Korea Market Analysis
            18.7.3.1. Introduction
            18.7.3.2. Market Analysis and Forecast by Market Taxonomy
                18.7.3.2.1. By Product
                18.7.3.2.2. By Cell Culture
                18.7.3.2.3. By Application
                18.7.3.2.4. By End User
19. South Asia Market Analysis
    19.1. Introduction
    19.2. Historical Market Size (US$ Million) Trend and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
    19.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032
        19.3.1. By Country
            19.3.1.1. India
            19.3.1.2. Indonesia
            19.3.1.3. Malaysia
            19.3.1.4. Thailand
            19.3.1.5. Rest of South Asia
        19.3.2. By Product
        19.3.3. By Cell Culture
        19.3.4. By Application
        19.3.5. By End User
    19.4. Market Attractiveness Analysis
        19.4.1. By Country
        19.4.2. By Cell Culture
        19.4.3. By Product
        19.4.4. By Application
        19.4.5. By End User
    19.5. Market Trends
    19.6. Drivers and Restraints - Impact Analysis
    19.7. Country-Level Analysis & Forecast
        19.7.1. India Market Analysis
            19.7.1.1. Introduction
            19.7.1.2. Market Analysis and Forecast by Market Taxonomy
                19.7.1.2.1. By Product
                19.7.1.2.2. By Cell Culture
                19.7.1.2.3. By Application
                19.7.1.2.4. By End User
        19.7.2. Indonesia Market Analysis
            19.7.2.1. Introduction
            19.7.2.2. Market Analysis and Forecast by Market Taxonomy
                19.7.2.2.1. By Product
                19.7.2.2.2. By Cell Culture
                19.7.2.2.3. By Application
                19.7.2.2.4. By End User
        19.7.3. Malaysia Market Analysis
            19.7.3.1. Introduction
            19.7.3.2. Market Analysis and Forecast by Market Taxonomy
                19.7.3.2.1. By Product
                19.7.3.2.2. By Cell Culture
                19.7.3.2.3. By Application
                19.7.3.2.4. By End User
        19.7.4. Thailand Market Analysis
            19.7.4.1. Introduction
            19.7.4.2. Market Analysis and Forecast by Market Taxonomy
                19.7.4.2.1. By Product
                19.7.4.2.2. By Cell Culture
                19.7.4.2.3. By Application
                19.7.4.2.4. By End User
20. Oceania Market Analysis
    20.1. Introduction
    20.2. Historical Market Size (US$ Million) Trend and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
    20.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032
        20.3.1. By Country
            20.3.1.1. Australia
            20.3.1.2. New Zealand
        20.3.2. By Product
        20.3.3. By Cell Culture
        20.3.4. By Application
        20.3.5. By End User
    20.4. Market Attractiveness Analysis
        20.4.1. By Country
        20.4.2. By Product
        20.4.3. By Cell Culture
        20.4.4. By Application
        20.4.5. By End User
    20.5. Key Market Participants - Intensity Mapping
    20.6. Drivers and Restraints - Impact Analysis
    20.7. Country-Level Analysis & Forecast
        20.7.1. Australia Market Analysis
            20.7.1.1. Introduction
            20.7.1.2. Market Analysis and Forecast by Market Taxonomy
                20.7.1.2.1. By Product
                20.7.1.2.2. By Cell Culture
                20.7.1.2.3. By Application
                20.7.1.2.4. By End User
        20.7.2. New Zealand Market Analysis
            20.7.2.1. Introduction
            20.7.2.2. Market Analysis and Forecast by Market Taxonomy
                20.7.2.2.1. By Product
                20.7.2.2.2. By Cell Culture
                20.7.2.2.3. By Application
                20.7.2.2.4. By End User
21. Middle East and Africa (MEA) Market Analysis
    21.1. Introduction
    21.2. Historical Market Size (US$ Million) Trend and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
    21.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032
        21.3.1. By Country
            21.3.1.1. GCC Countries
            21.3.1.2. Turkey
            21.3.1.3. North Africa
            21.3.1.4. South Africa
            21.3.1.5. Rest of Middle East and Africa
        21.3.2. By Product
        21.3.3. By Cell Culture
        21.3.4. By Application
        21.3.5. By End User
    21.4. Market Attractiveness Analysis
        21.4.1. By Country
        21.4.2. By Product
        21.4.3. By Cell Culture
        21.4.4. By Application
        21.4.5. By End User
    21.5. Market Trends
    21.6. Drivers and Restraints - Impact Analysis
    21.7. Country-Level Analysis & Forecast
        21.7.1. GCC Countries Market Analysis
            21.7.1.1. Introduction
            21.7.1.2. Market Analysis and Forecast by Market Taxonomy
                21.7.1.2.1. By Product
                21.7.1.2.2. By Cell Culture
                21.7.1.2.3. By Application
                21.7.1.2.4. By End User
        21.7.2. Turkey Market Analysis
            21.7.2.1. Introduction
            21.7.2.2. Market Analysis and Forecast by Market Taxonomy
                21.7.2.2.1. By Product
                21.7.2.2.2. By Cell Culture
                21.7.2.2.3. By Application
                21.7.2.2.4. By End User
        21.7.3. South Africa Market Analysis
            21.7.3.1. Introduction
            21.7.3.2. Market Analysis and Forecast by Market Taxonomy
                21.7.3.2.1. By Product
                21.7.3.2.2. By Cell Culture
                21.7.3.2.3. By Application
                21.7.3.2.4. By End User
        21.7.4. North Africa Market Analysis
            21.7.4.1. Introduction
            21.7.4.2. Market Analysis and Forecast by Market Taxonomy
                21.7.4.2.1. By Product
                21.7.4.2.2. By Cell Culture
                21.7.4.2.3. By Application
                21.7.4.2.4. By End User
22. Market Structure Analysis
    22.1. Market Analysis by Tier of Companies
    22.2. Market Share Analysis of Top Players
    22.3. Market Presence Analysis
23. Competition Analysis
    23.1. Competition Dashboard
    23.2. Competition Benchmarking
    23.3. Competition Deep Dive
        23.3.1. Thermo Fisher Scientific
            23.3.1.1. Overview
            23.3.1.2. Product Portfolio
            23.3.1.3. Sales Footprint
            23.3.1.4. Key Financials
            23.3.1.5. SWOT Analysis
            23.3.1.6. Strategy Overview
                23.3.1.6.1. Marketing Strategy
                23.3.1.6.2. Product Strategy
                23.3.1.6.3. Channel Strategy
        23.3.2. Corning Incorporated
            23.3.2.1. Overview
            23.3.2.2. Product Portfolio
            23.3.2.3. Sales Footprint
            23.3.2.4. Key Financials
            23.3.2.5. SWOT Analysis
            23.3.2.6. Strategy Overview
                23.3.2.6.1. Marketing Strategy
                23.3.2.6.2. Product Strategy
                23.3.2.6.3. Channel Strategy
        23.3.3. Merck KGaA
            23.3.3.1. Overview
            23.3.3.2. Product Portfolio
            23.3.3.3. Sales Footprint
            23.3.3.4. Key Financials
            23.3.3.5. SWOT Analysis
            23.3.3.6. Strategy Overview
                23.3.3.6.1. Marketing Strategy
                23.3.3.6.2. Product Strategy
                23.3.3.6.3. Channel Strategy
        23.3.4. Lonza
            23.3.4.1. Overview
            23.3.4.2. Product Portfolio
            23.3.4.3. Sales Footprint
            23.3.4.4. Key Financials
            23.3.4.5. SWOT Analysis
            23.3.4.6. Strategy Overview
                23.3.4.6.1. Marketing Strategy
                23.3.4.6.2. Product Strategy
                23.3.4.6.3. Channel Strategy
        23.3.5. Sartorius AG
            23.3.5.1. Overview
            23.3.5.2. Product Portfolio
            23.3.5.3. Sales Footprint
            23.3.5.4. Key Financials
            23.3.5.5. SWOT Analysis
            23.3.5.6. Strategy Overview
                23.3.5.6.1. Marketing Strategy
                23.3.5.6.2. Product Strategy
                23.3.5.6.3. Channel Strategy
        23.3.6. Hitachi. Ltd
            23.3.6.1. Overview
            23.3.6.2. Product Portfolio
            23.3.6.3. Sales Footprint
            23.3.6.4. Key Financials
            23.3.6.5. SWOT Analysis
            23.3.6.6. Strategy Overview
                23.3.6.6.1. Marketing Strategy
                23.3.6.6.2. Product Strategy
                23.3.6.6.3. Channel Strategy
        23.3.7. Nanoentek
            23.3.7.1. Overview
            23.3.7.2. Product Portfolio
            23.3.7.3. Sales Footprint
            23.3.7.4. Key Financials
            23.3.7.5. SWOT Analysis
            23.3.7.6. Strategy Overview
                23.3.7.6.1. Marketing Strategy
                23.3.7.6.2. Product Strategy
                23.3.7.6.3. Channel Strategy
        23.3.8. ChemoMetec
            23.3.8.1. Overview
            23.3.8.2. Product Portfolio
            23.3.8.3. Sales Footprint
            23.3.8.4. Key Financials
            23.3.8.5. SWOT Analysis
            23.3.8.6. Strategy Overview
                23.3.8.6.1. Marketing Strategy
                23.3.8.6.2. Product Strategy
                23.3.8.6.3. Channel Strategy
        23.3.9. Danaher corporation
            23.3.9.1. Overview
            23.3.9.2. Product Portfolio
            23.3.9.3. Sales Footprint
            23.3.9.4. Key Financials
            23.3.9.5. SWOT Analysis
            23.3.9.6. Strategy Overview
                23.3.9.6.1. Marketing Strategy
                23.3.9.6.2. Product Strategy
                23.3.9.6.3. Channel Strategy
        23.3.10. Agilent Technologies
            23.3.10.1. Overview
            23.3.10.2. Product Portfolio
            23.3.10.3. Sales Footprint
            23.3.10.4. Key Financials
            23.3.10.5. SWOT Analysis
            23.3.10.6. Strategy Overview
                23.3.10.6.1. Marketing Strategy
                23.3.10.6.2. Product Strategy
                23.3.10.6.3. Channel Strategy
        23.3.11. Perkin Elmer (Nexcelom Bioscience LLC.)
            23.3.11.1. Overview
            23.3.11.2. Product Portfolio
            23.3.11.3. Sales Footprint
            23.3.11.4. Key Financials
            23.3.11.5. SWOT Analysis
            23.3.11.6. Strategy Overview
                23.3.11.6.1. Marketing Strategy
                23.3.11.6.2. Product Strategy
                23.3.11.6.3. Channel Strategy
        23.3.12. F. Hoffmann-La Roche AG
            23.3.12.1. Overview
            23.3.12.2. Product Portfolio
            23.3.12.3. Sales Footprint
            23.3.12.4. Key Financials
            23.3.12.5. SWOT Analysis
            23.3.12.6. Strategy Overview
                23.3.12.6.1. Marketing Strategy
                23.3.12.6.2. Product Strategy
                23.3.12.6.3. Channel Strategy
        23.3.13. SHIMADZU CORPORATION
            23.3.13.1. Overview
            23.3.13.2. Product Portfolio
            23.3.13.3. Sales Footprint
            23.3.13.4. Key Financials
            23.3.13.5. SWOT Analysis
            23.3.13.6. Strategy Overview
                23.3.13.6.1. Marketing Strategy
                23.3.13.6.2. Product Strategy
                23.3.13.6.3. Channel Strategy
        23.3.14. Bio-Rad Laboratories
            23.3.14.1. Overview
            23.3.14.2. Product Portfolio
            23.3.14.3. Sales Footprint
            23.3.14.4. Key Financials
            23.3.14.5. SWOT Analysis
            23.3.14.6. Strategy Overview
                23.3.14.6.1. Marketing Strategy
                23.3.14.6.2. Product Strategy
                23.3.14.6.3. Channel Strategy
        23.3.15. Miltenyi Biotec
            23.3.15.1. Overview
            23.3.15.2. Product Portfolio
            23.3.15.3. Sales Footprint
            23.3.15.4. Key Financials
            23.3.15.5. SWOT Analysis
            23.3.15.6. Strategy Overview
                23.3.15.6.1. Marketing Strategy
                23.3.15.6.2. Product Strategy
                23.3.15.6.3. Channel Strategy
        23.3.16. Sinfonia Technology
            23.3.16.1. Overview
            23.3.16.2. Product Portfolio
            23.3.16.3. Sales Footprint
            23.3.16.4. Key Financials
            23.3.16.5. SWOT Analysis
            23.3.16.6. Strategy Overview
                23.3.16.6.1. Marketing Strategy
                23.3.16.6.2. Product Strategy
                23.3.16.6.3. Channel Strategy
        23.3.17. SHIBUYA CORPORATION
            23.3.17.1. Overview
            23.3.17.2. Product Portfolio
            23.3.17.3. Sales Footprint
            23.3.17.4. Key Financials
            23.3.17.5. SWOT Analysis
            23.3.17.6. Strategy Overview
                23.3.17.6.1. Marketing Strategy
                23.3.17.6.2. Product Strategy
                23.3.17.6.3. Channel Strategy
        23.3.18. Advanced Instruments
            23.3.18.1. Overview
            23.3.18.2. Product Portfolio
            23.3.18.3. Sales Footprint
            23.3.18.4. Key Financials
            23.3.18.5. SWOT Analysis
            23.3.18.6. Strategy Overview
                23.3.18.6.1. Marketing Strategy
                23.3.18.6.2. Product Strategy
                23.3.18.6.3. Channel Strategy
        23.3.19. Cell Culture Company, LLC
            23.3.19.1. Overview
            23.3.19.2. Product Portfolio
            23.3.19.3. Sales Footprint
            23.3.19.4. Key Financials
            23.3.19.5. SWOT Analysis
            23.3.19.6. Strategy Overview
                23.3.19.6.1. Marketing Strategy
                23.3.19.6.2. Product Strategy
                23.3.19.6.3. Channel Strategy
        23.3.20. BD
            23.3.20.1. Overview
            23.3.20.2. Product Portfolio
            23.3.20.3. Sales Footprint
            23.3.20.4. Key Financials
            23.3.20.5. SWOT Analysis
            23.3.20.6. Strategy Overview
                23.3.20.6.1. Marketing Strategy
                23.3.20.6.2. Product Strategy
                23.3.20.6.3. Channel Strategy
        23.3.21. Hamilton Company
            23.3.21.1. Overview
            23.3.21.2. Product Portfolio
            23.3.21.3. Sales Footprint
            23.3.21.4. Key Financials
            23.3.21.5. SWOT Analysis
            23.3.21.6. Strategy Overview
                23.3.21.6.1. Marketing Strategy
                23.3.21.6.2. Product Strategy
                23.3.21.6.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Recommendations

Packaging

Biodegradable Packaging Market

November 2024

REP-GB-323

250 pages

Packaging

FMCG Packaging Market

May 2023

REP-GB-110

324 pages

Packaging

Biodegradable Food Packaging Market

March 2023

REP-GB-12941

250 pages

Packaging

Intelligent Packaging Market

February 2023

REP-GB-13604

240 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Automated Cell Biology Systems Market

Schedule a Call